It has been an exciting month for HAVN Life Sciences (CNSX: HAVN) (OTCMKTS: HAVLF). In the news, HAVN just announced a strategic partnership with TheraPsil, the shipment of white label natural health products to their Australian distribution partner, and a supply agreement with Atman Retreat. We’re pleased to welcome HAVN CEO Tim Moore back to The Dales Report to discuss these updates, the company’s revenue potential, and more.
Share this post